Health Bulletin 11/October/2021

In the process of designing new legislation for drugs, cosmetics, and medical devices to replace the present Drugs and Cosmetics Act, which was enacted in 1940, the high-level government committee is going to consider decriminalising offences and intending to exclude penal elements in the case of a quality-related failure from the proposed Drugs and Cosmetics Act.

This came in line with the meeting earlier this month between the expert panel and concerned stakeholders, at which industry experts urged that criminal measures be removed from the draft copy of drugs and cosmetics Act in the scenario of a quality-related failure, as they led to harassment.